Skip to Content


Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Receipt Date; Correction

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 11449


Food and Drug Administration, HHS.


Notice; correction.


The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Friday, February 7, 2014 (79 FR 7463). The document announced the availability of a guidance entitled “Providing Regulatory Submissions in Electronic Format—Receipt Date.” The document was published with an incorrect Web site in the “Electronic Access” section. This document corrects that error.

Start Further Info


Marina Kalinina, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, rm. 1183, Silver Spring, MD 20993, 301-796-7591; or Stephen Ripley, Center for Biologics Evaluation and Research, Food and Drug Administration, 5515 Security Lane, rm. 5130, Rockville, MD 20852, 301-827-6210.

End Further Info End Preamble Start Supplemental Information


In FR Doc. 2014-02654, appearing on page 7463 in the Federal Register of Friday, February 7, 2014, the following correction is made:

1. On page 7464, in the first column, in the “Electronic Access” section, the Web site “​Drugs/​DevelopmentApprovalProcess/​FormsSubmissionRequirements/​ElectronicSubmissions/​ucm253101.htm” is corrected to read “​Drugs/​GuidanceComplianceRegulatoryInformation/​Guidances/​default.htm.

Start Signature

Dated: February 25, 2014.

Leslie Kux,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2014-04424 Filed 2-27-14; 8:45 am]